Beaird Harris Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Beaird Harris Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $33,165 - $37,786	-429 Reduced 83.63%	84 $6,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $26,735 - $38,382	429 Added 510.71%	513 $44,000
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $5,001 - $5,712	84 New	84 $5,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $17,893 - $20,153	-310 Closed	0 $0
Q1 2022 May 27, 2022	BUY	$57.92 - $72.58 $13,089 - $16,403	226 Added 269.05%	310 $18,000
Q4 2021 May 17, 2022	BUY	$64.88 - $73.64 $5,449 - $6,185	84 New	84 $6,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Beaird Harris Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Beaird Harris Wealth Management, LLC with notifications on news.